Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 107Lymphoid 87CNS 80Gastrointestinal 79Thoracic 54Breast 51Head & Neck 46Gynecologic 40Other hematologic neoplasm 34Sarcoma 32Plasma cell 29Dermatologic 26Tumor-Agnostic 19Endocrine 15Myeloid 10NET 8Other solid neoplasm 4Other neoplasm 2Other 1

Conditions

Gastric Adenocarcinoma 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

fludarabine 2Taxes 2Specimen Handling 2Paclitaxel 2Melphalan 2Magnetic Resonance Spectroscopy 2Educational Status 2Aminolevulinic Acid 2venetoclax 1tirbanibulin 1taxane 1radium Ra 223 dichloride 1fludarabine phosphate 1abemaciclib 1X-Rays 1Whole-Body Irradiation 1Tamoxifen 1Tacrolimus 1Surveys and Questionnaires 1Robotic Surgical Procedures 1Resistance Training 1Radiotherapy 1Platinum 1Photons 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Mycophenolic Acid 1Morphine 1Methods 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Magnetic Resonance Spectroscopy × Other neoplasm × 90 days × Clear all
NCT04090398 2026-05-13

Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones

National Cancer Institute (NCI)

Phase 2 Active not recruiting
70 enrolled
BreastOther neoplasm

Anatomic Stage IV Breast Cancer AJCC v8

NCT05753306 2026-04-08

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Mayo Clinic

Phase 2 Recruiting
40 enrolled
GastrointestinalOther neoplasm

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡